HSPA5 and infection: We further demonstrated that a humanized monoclonal antibody (hMAb159) with high affinity and specificity against GRP78 and a safe clinical profile in preclinical models (23) depletes csGRP78 and reduces cell surface ACE2 (csACE2), SARS-CoV-2 entry, and infection.